Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

219

Participants

Timeline

Start Date

September 4, 2013

Primary Completion Date

February 25, 2015

Study Completion Date

November 17, 2016

Conditions
Psoriatic Arthritis
Interventions
DRUG

Apremilast 30 mg

30mg of Apremilast will be orally administered twice daily for 104 weeks

DRUG

Placebo

Identically appearing Placebo tablets will be orally administered twice daily for up to 24 weeks

Trial Locations (71)

1036

Qualiclinic kft, Budapest

1640

Middlemore Clinical Trials, Manukau

2050

Royal Prince Alfred Hospital, Camperdown

2145

Westmead Cancer Care Center, Westmead, NSW

2217

Optimus Clinical Research Pty. Ltd, Kogarah

3128

Eastern Health Clinical School, Box Hill

3204

Waikato hospital, Hamilton

4032

Debreceni Egyetem Orvos- es Egeszsegtudomanyi Centrum, Debrecen

4558

Coastal Joint Care, Maroochydore

5000

MAV Korhaz es Rendelointezet Szolnok, Szolnok

6100

Colin Bayliss Research and Teaching Unit, Victoria Park

7000

Menzies Centre for Population Health Research, Hobart

8200

Veszprém Megyei Önkormányzat Csolnoky Ferenc Kórház-Rendelöintézet, Veszprém

8601

Timaru Hospital, Timaru

15006

Hospital Universitario a Coruna, A Coruña

15706

Hospital Clinico Universitario de Santiago, Santiago de Compostela

16635

Altoona Center for Clinical Research, Duncansville

26301

Mountain State Clinical Research, Clarksburg

27834

Physicians East, Greenville

28046

Hospital Universitario La Paz, Madrid

29009

Hospital General Carlos Haya, Málaga

33016

Palmetto Medical Research, Hialeah

33511

Bay Area Arthritis and Osteoporosis, Brandon

Health Point Medical Group, Brandon

34102

Jeffrey Alper MD Research, Naples

34652

Suncoast Clinical Research, New Port Richey

35216

Achieve Clinical Research LLC, Birmingham

38119

Ramesh C Gupta MD, Memphis

38305

West Tennessee Research Institute, Jackson

38320

Hospital Universitario de Canarias, San Cristóbal de La Laguna

48013

Hospital de Basurto-Osakidetza, Bilbao

48910

Advanced Rheumatology, Lansing

50106

Clinical Research Centre Ltd, Tartu

59901

Research West Incorporated, Kalispell

61107

Rockford Orthopedic Associates, LLC, Rockford

68134

Heartland Clinical Research, Inc., Omaha

75231

Baylor Research Institute, Dallas

77090

Houston Medical Research, Houston

78731

Austin Regional Clinic, Austin

79424

Arthritis and Osteoporosis Associates LLP, Lubbock

83814

Coeur D'Alene Arthritis Clinic, Coeur d'Alene

84132

University of Utah, Salt Lake City

92260

Desert Medical Advances, Palm Desert

150062

Yaroslavl Regional Clinical Hospital, Yaroslavl

214025

Departmental Hospital at Smolensk Station RZhD JSC, Smolensk

400006

Emergency County Clinical Hospital, Cluj-Napoca

420103

Research Medical Complex Vashe Zdorovie, Kazan'

440026

Penza Regional Clinical Hospital n.a. N.N. Burdenko, Penza

520052

SC Covamed SRL, Sfantu Gheorghe, Covasna

800578

Sf Apostol Andrei Emergency Clinical County Hospital, Galati

33612-4799

University of South Florida, Tampa

27103-3914

Piedmont Medical Research Associates Inc, Winston-Salem

V6J 1S3

Manna Research, Vancouver

R3A1M3

Manitoba Clinic, Winnipeg

A1A 4Y3

Karma Clinical Trials, St. John's

A1A 5E8

Nexus Clinical Research, St. John's

L8N 2B6

MAC Research Incorporated, Hamilton

M9C 5N2

Arthur Karasik Private Practice, Toronto

M9W4L6

Manna Research, Toronto

N8X 5A6

Jude Rodrigues Private Practice, Windsor

G1V 4G2

CHUL du CHU de Quebec, Québec

128 50

Revmatologicky ustav, Prague

140 00

Revmatologicka Ambulance, Prague

356 01

Revmatologicka Ambulance, Sokolov

760 01

PV - MEDICAL, s.r.o., Zlín

EE-10117

Innomedica Medical and Research Centre, Tallinn

EE-11412

East Tallinn Central Hospital, Tallinn

011172

Sf. Maria Clinical Hospital, Bucharest

08035

Hospital Vall d'Hebron, Barcelona

08907

Hospital Universitari de Bellvitge, Barcelona, Hospitalet de Llobregat

08208

Corporacion Sanitaria Parc Tauli, Sabadell

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY

NCT01925768 - Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis | Biotech Hunter | Biotech Hunter